The role of TRB3 in mast cells sensitized with monomeric IgE

Experimental and Molecular Pathology

Volumn 93, Issue 3, 2012, Pages 408-415

  Kuo, Chuan Hui ^a   Morohoshi, Kei ^b   Aye, Cho Cho ^a   Garoon, Robert B ^a   Collins, Andrea ^a   Ono, Santa Jeremy ^a,c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

IL 4; IL 6; Inflammation; MCP 1; TNF

Indexed keywords

CELL PROTEIN; CHEMOKINE; CHYMASE; CYTOKINE; I KAPPA B ALPHA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; INTERLEUKIN 6; SMALL INTERFERING RNA; TRIBBLES HOMOLOG 3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DISRUPTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; INFLAMMATION; MAST CELL; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; RNA INTERFERENCE; SENSITIZATION; SIGNAL TRANSDUCTION; TRB3 GENE;

ANIMALS; CELL LINE, TUMOR; CHEMOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOGLOBULIN E; MAST CELLS; MICE; MICE, INBRED BALB C; PROTEIN-SERINE-THREONINE KINASES; RATS; RNA, SMALL INTERFERING;

EID: 84872377134     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2012.09.008     Document Type: Article

References (48)

1. Alam R., et al. Macrophage inflammatory protein-1 α activates basophils and mast cells. The Journal of Experimental Medicine 1992, 176:781-786.
2. Baeuerle P.A. IkappaB-NF-kappaB structures: at the interface of inflammation control. Cell 1998, 95:729-731.
3. Baeuerle P.A., Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 1988, 242:540-546.
4. Baldwin A.S. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. The Journal of Clinical Investigation 2001, 107:241-246.
5. Beer F., et al. Role of β-chemokines in mast cell activation and type I hypersensitivity reactions in the conjunctiva: in vivo and in vitro studies. Immunological Reviews 2007, 217:96-104.
6. Bowers A.J., et al. SKIP3, a novel Drosophila tribbles ortholog, is overexpressed in human tumors and is regulated by hypoxia. Oncogene 2003, 22:2823-2835.
7. Chacon M.R., et al. Human serum levels of fetal antigen 1 (FA1/Dlk1) increase with obesity, are negatively associated with insulin sensitivity and modulate inflammation in vitro. International Journal of Obesity 2008, 32:1122-1129.
8. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
9. Fifadara, N., et al., 2009. CCR1 expression and signal transduction by murine BMMC results in secretion of TNF-α, TGFβ-1 and IL-6. International immunology 21(8), 991-1001.
10. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002, 109:S81-S96. (Suppl.).
11. Gu X., et al. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. The Journal of Biological Chemistry 2003, 278:42027-42035.
12. Jayapal M., et al. Genome-wide gene expression profiling of human mast cells stimulated by IgE or FcεRI-aggregation reveals a complex network of genes involved in inflammatory responses. BMC Genomics 2006, 7:210.
13. Jeong H.J., et al. Inhibition of TNF-alpha and IL-6 production by Aucubin through blockade of NF-kappaB activation RBL-2H3 mast cells. Cytokine 2002, 18:252-259.
14. Kalesnikoff J., et al. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 2001, 14:801-811.
15. Kaplanski G., et al. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends in Immunology 2003, 24:25-29.
16. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annual Review of Immunology 2000, 18:621-663.
17. Karin M., Lin A. NF-kappaB at the crossroads of life and death. Nature Immunology 2002, 3:221-227.
18. Kawakami T., Galli S.J. Regulation of mast-cell and basophil function and survival by IgE. Nature Reviews. Immunology 2002, 2:773-786.
19. Kawakami T., Kitaura J. Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance. The Journal of Immunology 2005, 175:4167-4173.
20. Kelly-Welch A.E., et al. Interleukin-4 and interleukin-13 signaling connections maps. Science 2003, 300:1527-1528.
21. Kinet J.P. The high-affinity IgE receptor (FcεRI): from physiology to pathology. Annual Review of Immunology 1999, 17:931-972.
22. Kiss-Toth E., et al. Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. The Journal of Biological Chemistry 2004, 279:42703-42708.
23. Kitamura H., et al. Bone marrow neutrophilia and suppressed bone turnover in human interleukin-6 transgenic mice. A cellular relationship among hematopoietic cells, osteoblasts, and osteoclasts mediated by stromal cells in bone marrow. The American Journal of Pathology 1995, 147:1682-1692.
24. Kitaura J., et al. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:12911-12916.
25. Libermann T.A., Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Molecular and Cellular Biology 1990, 10:2327-2334.
26. Miyazaki D., et al. Macrophage inflammatory protein-1α as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions. The Journal of Clinical Investigation 2005, 115:434-442.
27. Morohoshi K., et al. Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration. Journal of Autoimmunity 2009, 33:247-254.
28. Morse E., et al. PPARalpha ligands cause lymphocyte depletion and cell cycle block and this is associated with augmented TRB3 and reduced Cyclin B1 expression. Molecular Immunology 2009, 46:3454-3461.
29. Morse E., et al. TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1. American Journal of Physiology. Renal Physiology 2010, 299:F965-F972.
30. Ohoka N., et al. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. The EMBO Journal 2005, 24:1243-1255.
31. Ord D., Ord T. Mouse NIPK interacts with ATF4 and affects its transcriptional activity. Experimental Cell Research 2003, 286:308-320.
32. Peng Y., et al. Inhibition of IKK down-regulates antigen+IgE-induced TNF production by mast cells: a role for the IKK-IkappaB-NF-kappaB pathway in IgE-dependent mast cell activation. Journal of Leukocyte Biology 2005, 77:975-983.
33. Prussin C., Metcalfe D.D. 4. IgE, mast cells, basophils, and eosinophils. The Journal of Allergy and Clinical Immunology 2003, 111:S486-S494.
34. Richardson R.M., et al. Regulation of the human chemokine receptor CCR1: cross-regulation by CXCR1 and CXCR2. The Journal of Biological Chemistry 2000, 275:9201-9208.
35. Romano M., et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997, 6:315-325.
36. Sawada J., et al. Stem cell factor has a suppressive activity to IgE-mediated chemotaxis of mast cells. The Journal of Immunology 2005, 174:3626-3632.
37. Schindler R., et al. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990, 75:40-47.
38. Taub D.D., et al. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. The Journal of Clinical Investigation 1995, 95:1370-1376.
39. Taylor M.L., Metcalfe D.D. Mast cells in allergy and host defense. Allergy and Asthma Proceedings 2001, 22:115-119.
40. Tilg H., et al. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994, 83:113-118.
41. Toda M., et al. Impact of engagement of FcεRI and CC chemokine receptor 1 on mast cell activation and motility. The Journal of Biological Chemistry 2004, 279:48443-48448.
42. Vercelli D. The regulation of IgE synthesis. Clinical Allergy and Immunology 2002, 16:179-196.
43. Virani S.S., et al. Novel markers of inflammation in atherosclerosis. Current Atherosclerosis Reports 2008, 10:164-170.
44. Wu M., et al. SINK is a p65-interacting negative regulator of NF-kappaB-dependent transcription. The Journal of Biological Chemistry 2003, 278:27072-27079.
45. Xing Z., et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. The Journal of Clinical Investigation 1998, 101:311-320.
46. Yamaguchi M., et al. IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. The Journal of Experimental Medicine 1997, 185:663-672.
47. Yamaguchi M., et al. IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release. The Journal of Immunology 1999, 162:5455-5465.
48. Yano K., et al. Production of macrophage inflammatory protein-1alpha by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability. Laboratory Investigation 1997, 77:185-193.